Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7179818 Substituted aminoquinuclidine compounds

Patent 7179818 was granted and assigned to Ortho-McNeil Pharmaceutical on February, 2007 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

Ortho-McNeil Pharmaceutical

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Allen B. Reitz0

Robert E. Boyd0

Date of Patent

February 20, 2007

0

Patent Application Number

106845370

Date Filed

October 14, 2003

0

Patent Primary Examiner

Amelia A. Owens

0

Patent abstract

This invention is directed towards substituted aminoquinuclidine compounds useful as delta-opioid receptor modulators, delta-opioid receptor agonists useful as analgesics and delta-opioid receptor antagonists useful as immunosuppressants, antiinflammatory agents, agents for the treatment of neurological and psychiatric conditions, medicaments for drug and alcohol abuse, agents for treating gastritis and diarrhea, cardiovascular agents and agents for the treatment of respiratory diseases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7179818 Substituted aminoquinuclidine compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.